Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Institute of Hematology & Blood Diseases Hospital, China
West Virginia University
The University of Queensland
University of Miami
M.D. Anderson Cancer Center
University of Washington
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
Yale University
M.D. Anderson Cancer Center
University of Manitoba
Ohio State University Comprehensive Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Massachusetts General Hospital
St. Jude Children's Research Hospital
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
West Virginia University
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
University of Colorado, Denver
University of Utah
Washington University School of Medicine
Hoosier Cancer Research Network
University of Washington
Fred Hutchinson Cancer Center
Guangdong Second Provincial General Hospital
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
Northside Hospital, Inc.
Beijing 302 Hospital
Chinese PLA General Hospital
Ohio State University Comprehensive Cancer Center
Georgetown University